WBC LYSE
- UID
- IMP/IVD/2022/000075_89b71ada39e1430b35f3f975ee4ab51f_71917b54223f56d5ef5eec0cc23b49c3
- Device class
- Class B
- Brand name
- WBC Reagent, PART B
- License holder
- Abbott Healthcare Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- Act as the diluent for the WBC. Osmotically lyse the red cells. Act as a diluent for Reticulocytes
WBC LYSE is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000075_89b71ada39e1430b35f3f975ee4ab51f_71917b54223f56d5ef5eec0cc23b49c3. This device is marketed under the brand name WBC Reagent, PART B. The license holder is Abbott Healthcare Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.